MDxHealth S.A.
MDXH
NASDAQ·Healthcare·Medical - Diagnostics & Research·Mkt cap $38.4M
$0.75
▲ +3.06%
P/E
—
Mkt Cap
$38.4M
52-Wk Range
$0.40–$5.33
52-Week Range
$0.40 - $5.33
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 78.9% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary genomic and epigenetic testing technology
- Non-invasive diagnostic solutions reducing patient complications
- Established clinical evidence supporting test efficacy
- European and North American market presence with expansion capabilities
Bear Case
1 risk
- Low volatility (beta 0.4).
Growth
Revenue decline expected
Increasing prostate cancer screening and diagnosis rates globally
Value
Deep value opportunity - significant discount to sector peers
Momentum
Hot
+37.1% over 3m
Quality
Strong
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying MDXH right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
AUG 13, 2026
Reported EPS of -$0.18 vs -$0.19 consensus (+6.9% surprise). Revenue of $27.2M vs $26.1M expected (+4.1%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+6.9%
Revenue trend · last 8Q
—
—
+142%
+61%
+34%
+24%
+27%
+14%
Q2 22
Q4 22
Q2 23
Q4 23
Q2 24
Q4 24
Q2 25
Q4 25
$13.0M
$24.0M
$31.4M
$38.7M
$42.0M
$48.1M
$53.2M
$54.7M
Margins · last 8Q
Gross
53.6%
Operating
-21.2%
Profit
-34.4%
Wall Street consensus
3 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: BTIG · $4.00 · May 14, 2026
vs Industry
How MDXH stacks vs Medical - Diagnostics & Research
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.